葛兰素史克Glaxosmithkline（GSK）2024年可持续发展数据报告「LSE」（英文版）（15页）.pdf

1、1 March 2025GSK report against the following metrics for all sites under operational control as defined in our organisational boundary approach.Our reporting period covers 1 January to 31 December.GSK use December prior year as a proxy for December current year where data is not available.GSKs basel

2、ine year for its environmental targets is 2020.These environmental metrics were selected from the materiality assessment completed in 2021 and our published targets towards our net zero and nature positive ambition where indicators are available.Basis of reporting 2024:environmental dataSub-metricSc

3、opeAbsolute greenhouse gas emissions(GHG)from emissions(tCO2e which is converted to thousand tonnes CO2e for ease of reading)Scope 1Emissions from onsite fuel useEmissions from sales force vehicles Fugitive emissions of fluorinated gases(refrigerant losses,propellant losses)Scope 2Generation of purc

4、hased electricity following both market and location-based accountingGeneration of purchased heat/steam,cooling and compressed airScope 3Category 1:Purchased goods and servicesCategory 2:Capital goodsCategory 3:Fuel-and Energy-Related Activities(Transmission Losses)Category 4:Upstream Transportation

5、 and DistributionCategory 5:Waste Generated in OperationsCategory 6:Business TravelCategory 7:Employee commuting and working from homeCategory 11:Use of sold productsCategory 12:End of lifeCategory 15:InvestmentsScope 1&2 GHG emissions intensity from energyper m revenueper full time equivalent(FTE)E

6、nergy(GWh)Total energy for Operations%Renewable electricityNatural gas purchased,electricity used,exported electricity,coal,other fossil fuels,renewable heat,purchased heating and cooling,purchased non-renewable electricity,purchased renewable electricity,on-site renewably generated electricity.The